A recent study found that the most potent CD8 T cell—inducing influenza vaccine did not induce sufficient numbers of cross-reactive CD8 T cells to provide substantial protection against a lethal non-homologous influenza A virus challenge [4]. This evidence concerns the gene CD8A and influenza.